Latest news with #2bPrecise
Yahoo
11 hours ago
- Business
- Yahoo
Spartanburg Regional Healthcare System (SRHS) Deploys 2bPrecise Enterprise
Multi-year partnership affirms SHRS as a leader in precision care and genomics SPARTANBURG, S.C. and HOUSTON, June 25, 2025 /PRNewswire/ -- Spartanburg Regional Healthcare System (SRHS) today announced its deployment of the 2bPrecise® enterprise platform. Under this multi-year partnership, 2bPrecise-powered applications are now available across the SRHS care network, including a base of 700 physicians, six hospitals, and over 150 offices. The platform efficiently delivers, supports, and expands transformative precision care solutions directly within EHR workflows. SRHS selected multiple 2bPrecise-powered applications to support its system-wide genomics and precision care objectives, including for specialty oncology providers. 2bPrecise Diagnostic Workflow enables the delivery and utility of discrete results from multiple specialty laboratory providers; 2bPrecise Oncology Workflow provides specialty assessment capabilities for both somatic and germline data, potential therapies, and clinical trials; and 2bPrecise Precision Timeline's patented longitudinal framework helps providers easily analyze an entire patient's care history, interventions, and therapeutic processes. 2bPrecise also enables SRHS's support of population-scale pharmacogenomics and personalized medication management programs, powered by YouScript. "This partnership with 2bPrecise reinforces SRHS's commitment to precision medicine and healthcare innovation leadership, making it easier than ever for providers to access, assess, and incorporate precision care solutions into their existing workflows," said Charles Morrow, MD, Executive Vice President and Chief Operating Officer, SRHS. "SRHS is proud of initiatives that help improve care efficiency and increase the availability of innovative, personalized care for all patients we serve, and we look forward to expanding upon these efforts with 2bPrecise." 2bPrecise Enterprise is the flagship operating system for precision medicine, enabling care organizations to efficiently route and utilize discrete diagnostic results, genomic insights, and multi-source system data. Compared with single-use applications with limited utility, siloed solutions from data-hungry aggregators, or bespoke initiatives that often require years of costly, resource-intensive development, 2bPrecise Enterprise is a vendor-agnostic, EHR-agnostic platform that provides unmatched speed-to-value for the universal adoption and continued expansion of precision medicine solutions. "On behalf of the entire 2bPrecise team, we are excited to reach our production milestones with SHRS," said Joe Spinelli, Chief Strategy Officer, 2bPrecise. "The modular and scalable framework of 2bPrecise Enterprise is a perfect match with SHRS's ambition and vision to systematically unlock the true power of personalized medicine. We look forward to continuing to expand the scope of applications and impact from these programs." About Spartanburg Regional Healthcare SystemFounded in 1917, Spartanburg Regional Healthcare System (SRHS) is an integrated healthcare delivery system and one of the largest providers of regional care in South Carolina. With a mission of advancing health together, SRHS' footprint includes over six hospital campuses and 150 offices, and employs more than 10,000 associates and 700 physicians. For more, visit About 2bPrecise2bPrecise®, an Aranscia company, is a suite of diagnostic and precision medicine technologies that enable transformative solutions at the point of care. 2bPrecise efficiently routes genetic and genomic data from molecular labs and clinical data sets, synthesizing them into a single clinical-genomic workflow. Precision medicine insights are incorporated into a clinician's EHR workflow for immediate and timely use, with specialty application for oncology, pharmacogenomics, hereditary screening, and more. With discrete test results consolidated into an invaluable data set, provider organizations are equipped to drive efficient workflows for a range of genomic workflows including population analytics, clinical intervention programs, and research. For more information on 2bPrecise, please visit Media ContactKarina StabileAria Marketing for 2bPrecise(516) 317-5835397179@ View original content to download multimedia: SOURCE 2bPrecise
Yahoo
12-05-2025
- Business
- Yahoo
Aranscia Acquires Spesana
Electronic Health Systems Pioneer Carla Balch Joins Aranscia's Executive Leadership Team HOUSTON, May 12, 2025 /PRNewswire/ -- Aranscia, a global provider of award-winning clinical workflow and diagnostic technology solutions, today announced that it has acquired Spesana and its best-in-class suite of patient navigation, clinical collaboration, and oncology clinical decision support utilities. Spesana's Founder and CEO, Carla Balch, a leading pioneer in healthcare and oncology information systems, will serve as Executive Director across all Aranscia software solutions, including oversight of Spesana's continued commercial and technical expansion. Spesana, founded in 2019, has developed a healthcare platform that increases the velocity, efficiency, and utility of innovative precision medicine programs. The Company's patient navigation, prior authorization, clinical trial collaboration, and diagnostic workflow solutions are in use across over 140 clinical sites, and its blue-chip customer base includes leading payers, multi-site provider and oncology organizations, and diagnostic laboratories. Spesana clients have reported a 60% improvement in the use of appropriate precision medicine diagnostics by eliminating clinical overhead and process ambiguity with Spesana's intelligent platform utilities. Spesana will join the Aranscia portfolio of companies, each of which shares a synergistic mission of solving the tactical gaps in clinical workflows and democratizing access to the promises of precision care. This portfolio includes 2bPrecise, the award-winning platform for lab-agnostic, EMR-integrated solutions that deliver unparalleled speed-to-value in precision care; YouScript, a widely recognized leader in actionable, real-time personalized medication risk management and pharmacogenomics (PGx) insights; and AccessDx Laboratory, a CLIA-certified, CAP-accredited, and NYCQ molecular diagnostic laboratory with specialist expertise in PGx and other personalized diagnostics. "We warmly welcome the entire Spesana team and platform to the Aranscia family of companies," said Joe Spinelli, Chief Strategy Officer, Aranscia. "Spesana and Aranscia have a clear and shared mission of developing and implementing best-in-class utilities that improve clinical, financial, and operational workflows for providers and the patients they serve. Carla's experience as a proven operator, builder, and ally to clinical partners makes her a perfect fit to lead Aranscia's software efforts as we assert our unified focus on positively impacting outcomes at the point of care." Ms. Balch was previously President and CEO of Altos Solutions, which developed the first web-based oncology medical records company (OncoEMR), and was subsequently acquired by Flatiron Health (now part of Roche). Prior to Spesana, Ms. Balch also served as President of Nantcare, an oncology technology and clinical trials company, and as CEO of Inteliquet (acquired by IQVIA), an innovative clinical trial matching solution. Ms. Balch serves on the Healthcare Counsel of the Federal Reserve Bank of St. Louis. "We built Spesana to unify fragmented healthcare workflows, and joining Aranscia allows us to realize that mission at scale," said Carla Balch, CEO of Spesana. "Our teams share a commitment to modernizing the clinician experience by eliminating technology silos and delivering a seamless, integrated, HIPAA-compliant platform across all specialties and sites of care. Together, and in collaboration with the clinical partners we serve, we will continue to deliver solutions that improve both patient outcomes and provider experiences and help to enable more connected, efficient, and intelligent healthcare." About Aranscia:Aranscia delivers world-class diagnostic software, services, and testing innovations that help clinicians improve care outcomes. The Aranscia portfolio of companies, which includes 2bPrecise, AccessDx Laboratory, Spesana, and YouScript, have extensive practical expertise in molecular diagnostics, genomics, and digital-first clinical workflows. Aranscia enables clinical organizations to effectively utilize precision diagnostics for turnkey programs in fields such as pharmacogenomics, infectious disease management, precision oncology, and genetic screening. With a dual focus on simplicity and scalability, Aranscia's portfolio companies are the ideal partner for long-term, value-based precision medicine initiatives. For more information, please visit About Spesana:Spesana has developed a universal healthcare platform to increase the velocity of patient access to the right care through improving clinical, financial, and operational workflows. Founded in 2019 by an experienced team of electronic medical record pioneers, Spesana's framework for purpose driven healthcare interoperability incorporates a provider-centric approach to building solutions for challenges such as patient navigation, referral management, prior authorization, lab routing, and multi-site clinical collaboration. For more information, please visit Contact: Karina Stabile (516) 317-5835 395038@ View original content to download multimedia: SOURCE Aranscia Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
